NUPATHE INC.
Healthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY12 | FY11 | FY10 | |
|---|---|---|---|
| Revenue | — | — | — |
| Operating income | −$111.2M | −$21.8M | −$21.2M |
| Net income | −$6.3M | −$3.7M | −$24.4M |
| Total assets | $30.6M | $30.8M | $43.8M |
| Total liabilities | $27.6M | $17.9M | $9.5M |
| Equity | $3.0M | $13.0M | $34.3M |
| EPS (diluted) | — | — | — |
| Shares out. | 14.7M | 14.7M | 14.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2012- Operating margin
- —
- Net margin
- —
- Return on equity
- −208.6%
- Return on assets
- −20.5%
- Return on capital (ROCE)
- −405.2%
- Liabilities / assets
- 90.2%
- Debt / equity
- 9.16×
- Book value / share
- $0.20
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2012- Accruals / assets
- 302.8%high accruals
- Piotroski F-Score
- 2/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 warning● 0 good- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Safeguard Scientifics IncDirector | Feb 21, 2014 | U | 5.2M | $3.65 |
| Roche Robert P JrDirector | Feb 21, 2014 | U | 10,000 | $6.80 |
| Yetter Wayne P.Director | Feb 21, 2014 | D | 13,500 | $6.80 |
| Mclaughlin Gerald W.Officer — SVP, Chief Commercial Officer | Feb 21, 2014 | U | 11,771 | $6.80 |
| Federici William JDirector | Feb 21, 2014 | D | 13,500 | $6.80 |
| Goldan Keith A.Officer — CFO and SVP | Feb 21, 2014 | U | 18,875 | $6.80 |
| Cola Michael FDirector | Feb 21, 2014 | D | 13,500 | $6.80 |
| Datin James ADirector | Feb 21, 2014 | U | 20,620 | $6.80 |
| Sebree Terri BOfficer — President | Feb 21, 2014 | U | 176,699 | $6.80 |
| Anido ArmandoOfficer — Chief Executive Officer | Feb 21, 2014 | D | 1.3M | $6.80 |
| Marino Michael F IiiOfficer — SVP and General Counsel | Feb 21, 2014 | U | 10,992 | $6.80 |
| Glaxosmithkline Plc | Feb 6, 2014 | Conversion | 1.5M | $2.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsFeb 21, 2014
- Entered a material agreement · Terminated a material agreement · New financial obligation · Other material eventJan 21, 2014
- Entered a material agreementJan 14, 2014
- Entered a material agreementJan 9, 2014
- Entered a material agreement · Other material eventDec 16, 2013
- Results of operationsNov 14, 2013
- Entered a material agreementOct 15, 2013
- Entered a material agreement · New financial obligationSep 19, 2013
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BMar 19, 2014
- EFFECTMar 18, 2014
- EFFECTMar 18, 2014
- S-8 POSMar 18, 2014
- S-8 POSMar 18, 2014
- S-8 POSMar 18, 2014
- S-8 POSMar 18, 2014
- S-8 POSMar 18, 2014
- POS AMMar 18, 2014
- POS AMMar 18, 2014
- SC 13D/AFeb 25, 2014
- 4PRIMARY DOCUMENTFeb 25, 2014
- 4FORM 4 SUBMISSIONFeb 25, 2014
- 4FORM 4 SUBMISSIONFeb 25, 2014
- 4FORM 4 SUBMISSIONFeb 25, 2014
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.